Pregled bibliografske jedinice broj: 394563
Loss of heterozygosity analysis at the NF2 gene locus in sporadic colon cancer
Loss of heterozygosity analysis at the NF2 gene locus in sporadic colon cancer // ICR Centenary Conference / Marshall, Chris ; Collins, Ian ; de Bono, Johann (ur.).
London : Delhi: Institute of Cancer Research, 2009. str. P012-P012 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 394563 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Loss of heterozygosity analysis at the NF2 gene locus in sporadic colon cancer
Autori
Čačev, Tamara ; Kapitanović, Sanja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
ICR Centenary Conference
/ Marshall, Chris ; Collins, Ian ; de Bono, Johann - London : Delhi : Institute of Cancer Research, 2009, P012-P012
Skup
ICR Centenary Conference. Cancer Genes: Discovery and Exploitation
Mjesto i datum
London, Ujedinjeno Kraljevstvo, 08.06.2009. - 11.06.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
NF2; LOH; sporadic colon cancer
Sažetak
NF2 protein product merlin is predominantly localized to the membrane-cytoskeleton interface and has a role in receiving extracellular signals and controlling cell-cell and cell-ECM communication, motility and differentiation. Since these processes are essential for tumorigenesis and metastasis in general, we decided to examine the possible role of NF2 in sporadic colon cancer development and progression. We examined 130 cases of human sporadic colon cancer and corresponding normal tissue samples to evaluate the loss of heterozygosity (LOH) at the NF2 gene loci. Three VNTR intragenic polymorphic markers, NF2CAIV, NF2CAV and NF2TET were analysed. NF2 LOH was detected in 20.8% of informative tumours. No statistically significant correlation was found between NF2 LOH and histological grade of tumours. LOH was present in 5.9% of well, 35.2% of moderately and 38.5% of poorly differentiated tumours. A positive trend was observed between NF2 LOH and Dukes' stage of tumours: NF2 LOH was detected in 16.0% of Dukes' A, 26.7% of Dukes' B, and 37.1% of Dukes' C tumours. Since NF2 LOH was more frequent in more advanced, metastatic tumours, this implicates NF2 in sporadic colon cancer development and progression.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2508 - Molekularna genetika i farmakogenetika gastrointestinalnih tumora (Kapitanović, Sanja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb